Irwin Naturals, Inc. Stock Canadian Securities Exchange

Equities

IWIN

CA46414Q1054

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:04:14 2024-04-30 pm EDT 5-day change 1st Jan Change
0.3 CAD +150.00% Intraday chart for Irwin Naturals, Inc. -.--% +57.89%
Sales 2021 100M 137M Sales 2022 89.47M 122M Capitalization 7.82M 10.65M
Net income 2021 8M 10.9M Net income 2022 -3M -4.09M EV / Sales 2021 0.13 x
Net Debt 2021 9.35M 12.74M Net Debt 2022 20.53M 27.97M EV / Sales 2022 0.32 x
P/E ratio 2021
105 x
P/E ratio 2022
-0.94 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 1.04%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Irwin Naturals, Inc.

1 month+46.34%
3 months+53.85%
6 months-57.14%
Current year+57.89%
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 02-01-22
Investor Relations Contact - -
Members of the board TitleAgeSince
Chief Executive Officer 58 02-01-22
Director/Board Member 41 -
Director/Board Member 52 -
More insiders
Irwin Naturals Inc. (Irwin) is a nutraceutical company. The Company is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products is available in more than 100,000 retail doors across North America. The Company's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The Company's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.
More about the company